Elevai Labs, Inc. Common Stock (ELAB) — Defensive Interval Ratio
Elevai Labs, Inc. Common Stock (ELAB) has a Defensive Interval Ratio of 84 days as of December 2025. Defensive assets of $912.59K (cash $-, short-term investments $572.05K, receivables $340.53K) cover 84 days of daily cash needs of $10.80K/day. See Elevai Labs, Inc. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Elevai Labs, Inc. Common Stock Defensive Interval Ratio (2020–2025)
This chart shows how Elevai Labs, Inc. Common Stock's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 84 days, meaning defensive assets of $912.59K can fund 84 days of operations without new revenue. See ELAB equity to assets ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Elevai Labs, Inc. Common Stock (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Elevai Labs, Inc. Common Stock from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Elevai Labs, Inc. Common Stock.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 84 days | $912.59K | $10.80K/day | $- | $572.05K | ▲ +83 days |
| 2024 | 1 days | $5.28K | $4.93K/day | $- | $0.00 | ▼ -9 days |
| 2023 | 10 days | $36.16K | $3.55K/day | $- | $- | ▲ +2 days |
| 2022 | 8 days | $12.85K | $1.61K/day | $- | $- | ▲ +5 days |
| 2021 | 3 days | $1.71K | $590.75/day | $- | $- | ▼ 0 days |
| 2020 | 3 days | $371.00 | $111.26/day | $- | $- | — |